Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global Newborn Screening Instruments market in this environment.
In terms of revenue, this research report indicated that the global Newborn Screening Instruments market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Newborn Screening Instruments industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Perkinelmer aims at producing XX K Units Newborn Screening Instruments in 2020, with XX % production to take place in global market, Waters accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Newborn Screening Instruments Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Newborn Screening Instruments Market
Perkinelmer
Waters
Natus Medical
GE Healthcare
AB Sciex
Thermo Fisher
Trivitron Healthcare
Agilent Technologies
Bio-Rad Laboratories
Medtronic
Masimo
...
Major Type of Newborn Screening Instruments Covered in Prudent Markets report:
Disorder Screening
Hearing Screening
Pulse Oximetry Screening
Application Segments Covered in Prudent Markets Market
Hearing Screening Test
CCHD Test
Dry Blood Spot Test
Other
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Newborn Screening Instruments Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Disorder Screening -Product Introduction and Major Manufacturers
1.1.2 Hearing Screening -Product Introduction and Major Manufacturers
1.1.3 Pulse Oximetry Screening -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Newborn Screening Instruments Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Newborn Screening Instruments Market
3.1.1 Top Companies leading Newborn Screening Instruments Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Newborn Screening Instruments Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Newborn Screening Instruments Market
3.2.1 Top Companies leading Newborn Screening Instruments Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Newborn Screening Instruments Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Newborn Screening Instruments Market
3.3.1 Top Companies leading Newborn Screening Instruments Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Newborn Screening Instruments Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Newborn Screening Instruments Market
3.4.1 Top Companies leading Newborn Screening Instruments Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Newborn Screening Instruments Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Newborn Screening Instruments Market
3.5.1 Top Companies leading Newborn Screening Instruments Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Newborn Screening Instruments Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Newborn Screening Instruments Market
3.6.1 Top Companies leading Newborn Screening Instruments Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Newborn Screening Instruments Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Newborn Screening Instruments Market
3.7.1 Top Companies leading Newborn Screening Instruments Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Newborn Screening Instruments Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 Newborn Screening Instruments Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Newborn Screening Instruments Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global Newborn Screening Instruments Sales and Growth Rate (2021-2027)
5.2 Global Newborn Screening Instruments Sales Value and Growth Rate (2021-2027)
6 Newborn Screening Instruments Competitive Analysis
6.1 Perkinelmer
6.1.1 Perkinelmer Company Profiles
6.1.2 Perkinelmer Product Introduction
6.1.3 Perkinelmer Newborn Screening Instruments Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 Waters
6.2.1 Waters Company Profiles
6.2.2 Waters Product Introduction
6.2.3 Waters Newborn Screening Instruments Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 Natus Medical
6.3.1 Natus Medical Company Profiles
6.3.2 Natus Medical Product Introduction
6.3.3 Natus Medical Newborn Screening Instruments Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 GE Healthcare
6.4.1 GE Healthcare Company Profiles
6.4.2 GE Healthcare Product Introduction
6.4.3 GE Healthcare Newborn Screening Instruments Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 AB Sciex
6.5.1 AB Sciex Company Profiles
6.5.2 AB Sciex Product Introduction
6.5.3 AB Sciex Newborn Screening Instruments Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 Thermo Fisher
6.6.1 Thermo Fisher Company Profiles
6.6.2 Thermo Fisher Product Introduction
6.6.3 Thermo Fisher Newborn Screening Instruments Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 Trivitron Healthcare
6.7.1 Trivitron Healthcare Company Profiles
6.7.2 Trivitron Healthcare Product Introduction
6.7.3 Trivitron Healthcare Newborn Screening Instruments Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Agilent Technologies
6.8.1 Agilent Technologies Company Profiles
6.8.2 Agilent Technologies Product Introduction
6.8.3 Agilent Technologies Newborn Screening Instruments Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Bio-Rad Laboratories
6.9.1 Bio-Rad Laboratories Company Profiles
6.9.2 Bio-Rad Laboratories Product Introduction
6.9.3 Bio-Rad Laboratories Newborn Screening Instruments Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 Medtronic
6.10.1 Medtronic Company Profiles
6.10.2 Medtronic Product Introduction
6.10.3 Medtronic Newborn Screening Instruments Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 Masimo
7 Conclusion